This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
CMC, which will be 51% owned by Bostik for an investment of around $11 million, will produce specialty cyanoacrylate monomers on an industrial scale at a competitive cost.
Arkema recently announced an investment in Crackless Monomer Co. (CMC), a joint venture between Bostik and Taiwanese company Cartell Chemical Co., to accelerate the development and production of high-value-added engineering adhesives.
The past year embodies the old proverb that “necessity is the mother of invention.” From remote schooling and work to virtual meetings and celebrations, COVID-19’s rapid spread and continued threat forced us to create new ways to lead productive lives as safely as possible.
Medical device manufacturers can find success when they embed processes and systems in a holistic manufacturing concept that takes into account the entire value chain.
The medical technology industry is growing faster than others and is currently experiencing a real change: more and more innovative products are being developed to help patients and relieve the burden on the healthcare system in the long term.
With applications ranging from over-the-counter medications and nutraceuticals to blood bags and syringes, the process of matching adhesive to end use in this highly regulated industry can be challenging.
It shouldn’t surprise anyone that the adhesive requirements for labels in the medical and pharmaceutical industry are diverse and demanding. With applications ranging from over-the-counter medications and nutraceuticals to blood bags and syringes, the process of matching adhesive to end use in this highly regulated industry is more involved than in almost any other segment.
The current COVID-19 pandemic has put global healthcare systems under tremendous pressure. While some of the impacts are short term, others are considered transformative.
In terms of value, the global ultraviolet (UV) adhesives market is anticipated to expand at a CAGR of around 8% from 2020-2030 and reach approximately $900 million by 2030.
The targeted investments include increasing supply capacities with manufacturing improvements at DuPont’s Healthcare Industries Materials Site in Hemlock, Mich.
DuPont recently announced that it is making significant investments in both capital and resources to strengthen strategic capabilities of its Liveo brand healthcare silicone solutions.
According to Master Bond, its EP42HT-4AOMed Black epoxy adhesive withstands aggressive chemical sterilants, radiation, and repeated cycles of autoclaving.
The Adhesive and Sealant Council (ASC) announces its Training Academy schedule for 2014 which will include 14 new program titles that includes a blend of 101/201 training, business trends webinars and value-added regulatory topics. Read More
The latest news and information
Content focused on adhesive & sealant manufacturing, formulations and finished products
